Cytokinetics Faces Class Action Lawsuit Over Securities Violations by DJS Law Group Cytokinetics is facing a class action lawsuit for securities law violations tied to misleading statements about FDA approval. Shareholders can seek recovery.

Cytokinetics Faces Class Action Lawsuit Over Securities Violations by DJS Law Group #United_States #Los_Angeles #Securities_Law #Cytokinetics #Law_Group